Patent ID: 6900161

Claim:
A compound of formula (Ia) or (Ib): wherein X is N or CH; Ar 1 is a carbocyclic or heterocyclic aryl non substituted or substituted by one or more R 2 , R 3 or R 4 ; Ar 2 is phenylene or naphthalene non substituted or substituted by one or more R 5 , R 6 or R 7 ; Ar 3 is a carbocyclic or heterocyclic aryl non substituted or substituted by one or more R 8 , R 9 or R 10 ; A is (C 1 -C 4 )-alkylene; B is —CH═CH—(C 1 -C 4 )-alkylene- or -cyclopropylene-(C 1 -C 4 )-alkylene-, wherein said cyclopropylene or —CH═CH— being non substituted or substituted by R 2 or R 3 ; R 1 is hydrogen, —SO 3 H or (C 1 -C 6 )-alkyl non substituted or substituted by R 2 or alkylene linked to Ar 3 ; R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 or R 10 , identical or different, are independently selected from the group consisting of: fluorine, chlorine, bromine, cyano, mono-bi- or trihalogeno(C 1 -C 8 )alkyl, mono-bi- or trihalogeno(C 1 -C 8 )-alkyloxy, hydroxy, nitro, carboxyl, formyl, —SO 3 H, —OSO 3 H, (R 11 O) 2 P(O)—, (R 11 O) 2 P(O)—O—, amino, (C 1 -C 8 )-alkylamino, di((C 1 -C 8 )alkyl)amino, (C 5 -C 14 )-aryl-(C 1 -C 6 )-alkylenamino or (C 5 -C 14 )-arylamino, (C 1 -C 8 )-alkyl, (C 5 -C 14 )-aryl, a heterocycle optionally substituted by oxo, (C 5 -C 14 )-aryl-(C 1 -C 6 )alkyl, amino-(C 1 -C 6 )-alkyl, (C 1 -C 8 )-alkylamino-(C 1 -C 6 )-alkyl, di-((C 1 -C 8 )alkyl)amino-(C 1 -C 6 )-alkyl, hydroxy-(C 1 -C 6 )alkyl, (C 1 -C 6 )-alkyloxy-(C 1 -C 6 )-alkyl, (C 1 -C 8 )-alkyloxy optionally interrupted by one or more oxygen atoms, (C 5 -C 14 )-aryl-(C 1 -C 6 )-alkylenoxy, (C 5 -C 14 )-aryloxy, hydroxy-(C 1 -C 6 ) alkylenoxy, (C 1 -C 6 )-alkyloxy-(C 1 -C 6 )alkylenoxy, amino-(C 1 -C 6 )-alkylenoxy, (C 1 -C 6 )-alkylamino-(C 1 -C 6 )-alkylenoxy, di((C 1 -C 8 )-alkyl)amino-(C 1 -C 6 )-alkylenoxy, methylenedioxy, (C 1 -C 6 )-alkyloxycarbonyl, (C 1 -C 6 )-alkylcarbonyl, (C 5 -C 14 )aryl-(C 1 -C 6 )-alkylenecarbonyl, (C 5 -C 14 )-aryl-carbonyl, (C 1 -C 6 )-alkylaminocarbonyl, (C 1 -C 6 )alkanoylamino, (C 1 -C 6 )-alkylsulfonylamino, (C 5 -C 14 )-arylsulfonylamino, (C 5 -C 14 )-aryl-(C 1 -C 6 )-alkylenesulfonylamino, (C 1 -C 6 )-alkylaminosulfonyl, (C 5 -C 14 )-aryl-(C 1 -C 6 )-alkylenaminosulfonyl, (C 1 -C 6 )-alkylsulfonyl, (C 5 -C 14 )-aryl-(C 1 -C 8 )-alkylenesulfonyl or (C 5 -C 14 )-aryl-sulfonyl, wherein said alkyl, aryl or heterocycle being themselves non substituted or substituted by one or more of the groups mentioned above; R 11 is hydrogen, (C 1 -C 10 )-alkyl, (C 6 -C 14 )-aryl or (C 6 -C 14 )-aryl-(C 1 -C 6 )-alkyl; or a stereoisomeric form or a mixture thereof, or a physiologically acceptable addition salt thereof or a prodrug thereof.